Tema ETFs’s Ascentage Pharma AAPG Stock Holding History

Tema ETFs’s Portfolio AAPG Stock Details AAPG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,385	Closed	-$405K	–	609
2025 Q3	$405K	Sell	10,385 -5,110	-33%	-$207K	0.03%	414
2025 Q2	$610K	Buy	+15,495	New	+$408K	0.16%	128

Other funds holding AAPG

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BIA

Bell Investment Advisors Oakland, California $639M AUM 13.28% 1-Year Est. Return

Tema ETFs's AAPG Position: Q4 2025 in Review

Tema ETFs sold out of Ascentage Pharma (AAPG) in Q4 2025, closing a stake of 10,385 shares — an estimated $405K sold.

Tema ETFs first reported a position in AAPG in Q2 2025 and held it in 2 quarters. The position peaked at $610K in Q2 2025. 12 funds tracked by Wall St. Rank hold AAPG as of Q4 2025.

Tema ETFs reported no remaining Ascentage Pharma position as of Q4 2025 after selling out during the quarter.
Tema ETFs sold 10,385 Ascentage Pharma shares in Q4 2025, an estimated $405K.
Tema ETFs first reported a position in Ascentage Pharma in Q2 2025 and held it in 2 quarters.
Tema ETFs's Ascentage Pharma position peaked at $610K in Q2 2025.
12 funds tracked by Wall St. Rank held Ascentage Pharma as of Q4 2025.

Based on Tema ETFs's 13F filing for Q4 2025, filed 16 Jan 2026.